Reasons for risk-reducing mastectomy versus MRI-screening in a cohort of women at high hereditary risk of breast cancer

被引:26
|
作者
Haroun, Iman
Graham, Tracy
Poll, Aletta
Sun, Ping
Hill, Kimberley [1 ]
Weitzner, Eleanor [2 ]
Narod, Steven [3 ]
Warner, Ellen [3 ]
机构
[1] Sunnybrook Odette Canc Ctr, Dept Med, Div Med Oncol, Toronto, ON, Canada
[2] Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada
[3] Univ Toronto, Toronto, ON M5S 1A1, Canada
来源
BREAST | 2011年 / 20卷 / 03期
关键词
BRCA1; MRI; Mastectomy; BRCA2; Surveillance; BILATERAL PROPHYLACTIC MASTECTOMY; BRCA2 MUTATION CARRIERS; TAMOXIFEN; IMPACT;
D O I
10.1016/j.breast.2011.01.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: To determine the reasons that motivate women in a cohort of women under intensive surveillance for breast cancer to undergo risk-reducing mastectomy (RRM). Patients and methods: Women with a BRCA1 or BRCA2 mutation who were enrolled in an MRI-based breast screening study were eligible to participate in this survey. A self-administered questionnaire was given to women who did, and who did not terminate annual MRI-based surveillance in order to undergo RRM. The questionnaire included information on family history, risk perception and satisfaction with screening. In addition, women were asked to provide the principal reason for their choice of having preventive surgery or not, and were asked about their satisfaction with this choice. Results: 246 women without breast cancer participated in the study. Of these, 39 women (16%) elected to have RRM at some point after initiating screening. Although women who had a mother or sister with breast cancer were more likely to opt for RRM than were women with no affected first-degree relative (21% versus 10%) this did not reach statistical significance. Women who perceived their breast cancer risk to be greater than 50% were more likely to opt for RRM than were women who estimated their risk to be less than 50% (19% versus 6%). Fear of cancer was the most common reason cited for choosing to have RRM (38% of respondents) followed by having had a previous cancer, (25%), then concern over their children (16%). Conclusion: Among women with a BRCA mutation who are enrolled in an MRI-based screening program, a high perception of personal breast cancer risk and a history of breast cancer in a first-degree relative are predictors of the decision to have RRM. (C) 2011 Published by Elsevier Ltd.
引用
收藏
页码:254 / 258
页数:5
相关论文
共 50 条
  • [31] Role of MRI in screening women at high risk for breast cancer
    Lehman, Constance D.
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2006, 24 (05) : 964 - 970
  • [32] MRI screening for breast cancer in women with high familial risk
    Kriege, M
    Brekelmans, C
    Boetes, C
    Rutgers, E
    Oosterwijk, J
    Tollenaar, R
    Manoliu, R
    Holland, R
    De Koning, H
    Klijn, J
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S51 - S51
  • [33] Breast cancer screening in women at high risk using MRI
    Leach, Martin O.
    NMR IN BIOMEDICINE, 2009, 22 (01) : 17 - 27
  • [34] MRI screening for breast cancer in women at high risk; isthe Australian breast MRI screening access program addressing the needs of women at high risk of breast cancer?
    Schenberg, Tess
    Mitchell, Gillian
    Taylor, Donna
    Saunders, Christobel
    JOURNAL OF MEDICAL RADIATION SCIENCES, 2015, 62 (03): : 212 - 225
  • [35] Women's constructions of the 'right time' to consider decisions about risk-reducing mastectomy and risk-reducing oophorectomy
    Howard, A. Fuchsia
    Bottorff, Joan L.
    Balneaves, Lynda G.
    Kim-Sing, Charmaine
    BMC WOMENS HEALTH, 2010, 10
  • [36] Breast cancer screening in women at high risk of hereditary breast cancer: an Australian experience
    Bennett, Ian
    Tourani, Saam
    Cockburn, Linda
    Reasbeck, Jane
    Grobbelaar, Neels
    Dann, Sonia
    Patrikios, Penny
    Brazier, Jane
    ANZ JOURNAL OF SURGERY, 2021, 91 (04) : 685 - 690
  • [37] Women's constructions of the 'right time' to consider decisions about risk-reducing mastectomy and risk-reducing oophorectomy
    A Fuchsia Howard
    Joan L Bottorff
    Lynda G Balneaves
    Charmaine Kim-Sing
    BMC Women's Health, 10
  • [38] A categorised approach for women with a diagnosis of breast cancer and a negative breast cancer susceptibility gene test requesting risk-reducing mastectomy
    Kerr, A.
    Kulkarni, A.
    Izatt, L.
    Shaw, A.
    DeSouza, B.
    Ruddy, D.
    Rose, S.
    Cameron, J.
    Tripathi, V.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2020, 28 (SUPPL 1) : 521 - 521
  • [39] CLINICAL AND PATHOLOGIC FINDINGS OF RISK-REDUCING SURGERY IN HIGH-RISK BREAST/OVARIAN CANCER WOMEN
    Cardoso, M.
    Reis de Carvalho, C.
    Aquino, J.
    Correia, L.
    Lopez, B.
    Bernardino, M.
    Jorge, A. F.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A560 - A560
  • [40] Risk-reducing mastectomy decisions among women with mutations in high- and moderate- penetrance breast cancer susceptibility genes
    Comeaux, Jacob G.
    Culver, Julie O.
    Lee, John E.
    Dondanville, Danielle
    McArthur, Heather L.
    Quinn, Emily
    Gorman, Nicholas
    Ricker, Charite
    Li, Ming
    Lerman, Caryn
    MOLECULAR GENETICS & GENOMIC MEDICINE, 2022, 10 (10):